Vacciguard Novel Vaccines

Vacciguard novel vaccines

 

HSP-60 peptide conjugates convert a weak antigen into a strong immunogen

Proof of Concept Print E-mail

Proof- of -concept has been demonstrated by repeated tests of three bacterial and two viral pathogens in mouse models.

Polysaccharide antigens were derived from bacteria capsule of:

 

Peptide antigens are derived from the following viruses:

 

Mice immunized with VacciGuard's vaccines were highly protected from pathogenic challenge compared to the control groups (the antigen alone/ the peptide carrier alone).

 

 

 

 

Tests in mouse models